(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FNDC3B mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1343110 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FNDC3B mRNA CTD PMID:22079256 1,2-dimethylhydrazine affects expression ISO RGD:1551864 6480464 1, 2-Dimethylhydrazine affects the expression of FNDC3B mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1551864 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FNDC3B mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1551864 6480464 Ethinyl Estradiol affects the expression of FNDC3B mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FNDC3B mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:1343110 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of FNDC3B mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of FNDC3B mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of FNDC3B mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1343110 6480464 Estradiol results in increased expression of FNDC3B mRNA CTD PMID:19619570 , PMID:31614463 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1551864 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1343110 6480464 Tetrachlorodibenzodioxin results in increased expression of FNDC3B mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551864 6480464 Tetrachlorodibenzodioxin results in decreased expression of FNDC3B mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551864 6480464 Tetrachlorodibenzodioxin affects the expression of FNDC3B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FNDC3B mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FNDC3B mRNA CTD PMID:15644576 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1343110 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of FNDC3B mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551864 6480464 Tetrachlorodibenzodioxin results in increased expression of FNDC3B mRNA CTD PMID:19465110 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FNDC3B mRNA CTD PMID:21346803 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of FNDC3B mRNA CTD PMID:21061450 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1343110 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FNDC3B mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1551864 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FNDC3B mRNA CTD PMID:30951980 5-fluorouracil decreases expression ISO RGD:1343110 6480464 Fluorouracil results in decreased expression of FNDC3B mRNA CTD PMID:16510598 5-fluorouracil affects response to substance ISO RGD:1343110 6480464 FNDC3B protein affects the susceptibility to Fluorouracil CTD PMID:16217747 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FNDC3B mRNA CTD PMID:31881176 aflatoxin B1 multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of FNDC3B mRNA CTD PMID:25450479 aflatoxin B1 increases methylation ISO RGD:1343110 6480464 Aflatoxin B1 results in increased methylation of FNDC3B gene CTD PMID:28458013 all-trans-retinoic acid increases expression ISO RGD:1343110 6480464 Tretinoin results in increased expression of FNDC3B mRNA CTD PMID:23724009 , PMID:33167477 aristolochic acid A decreases expression ISO RGD:1343110 6480464 aristolochic acid I results in decreased expression of FNDC3B mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1551864 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of FNDC3B mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1343110 6480464 Arsenic affects the methylation of FNDC3B gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1343110 6480464 Arsenic affects the methylation of FNDC3B gene CTD PMID:25304211 benzo[a]pyrene decreases expression ISO RGD:1551864 6480464 Benzo(a)pyrene results in decreased expression of FNDC3B mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1343110 6480464 Benzo(a)pyrene affects the methylation of FNDC3B 5' UTR, Benzo(a)pyrene affects the methylation of FNDC3B intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1551864 6480464 Benzo(a)pyrene results in decreased methylation of FNDC3B intron CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1343110 6480464 Benzo(a)pyrene results in increased methylation of FNDC3B 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1343110 6480464 Benzo(a)pyrene results in decreased expression of FNDC3B mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1343110 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene increases methylation ISO RGD:1343110 6480464 benzo(e)pyrene results in increased methylation of FNDC3B intron CTD PMID:30157460 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FNDC3B mRNA CTD PMID:25181051 , PMID:29097150 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FNDC3B mRNA CTD PMID:32145629 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FNDC3B mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A multiple interactions ISO RGD:1343110 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FNDC3B mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:1343110 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of FNDC3B gene CTD PMID:31601247 caffeine increases phosphorylation ISO RGD:1343110 6480464 Caffeine results in increased phosphorylation of FNDC3B protein CTD PMID:35688186 carbamazepine affects expression ISO RGD:1343110 6480464 Carbamazepine affects the expression of FNDC3B mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1551864 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1343110 6480464 CGP 52608 promotes the reaction [RORA protein binds to FNDC3B gene] CTD PMID:28238834 chloropicrin decreases expression ISO RGD:1343110 6480464 chloropicrin results in decreased expression of FNDC3B mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1551864 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of FNDC3B, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FNDC3B gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:1343110 6480464 Cisplatin results in decreased expression of FNDC3B mRNA CTD PMID:19561079 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FNDC3B mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:1343110 6480464 cobaltous chloride results in decreased expression of FNDC3B mRNA CTD PMID:19320972 cobalt dichloride affects expression ISO RGD:1343110 6480464 cobaltous chloride affects the expression of FNDC3B mRNA alternative form CTD PMID:19320972 copper atom multiple interactions ISO RGD:1551864 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FNDC3B mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1551864 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FNDC3B mRNA CTD PMID:15467011 coumestrol decreases expression ISO RGD:1343110 6480464 Coumestrol results in decreased expression of FNDC3B mRNA CTD PMID:19167446 cyclophosphamide affects response to substance ISO RGD:1343110 6480464 FNDC3B protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 cyclosporin A increases expression ISO RGD:1343110 6480464 Cyclosporine results in increased expression of FNDC3B mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1343110 6480464 Cyclosporine results in decreased expression of FNDC3B mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:1343110 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FNDC3B mRNA CTD PMID:28628672 diclofenac increases expression ISO RGD:1551864 6480464 Diclofenac results in increased expression of FNDC3B mRNA CTD PMID:26934552 dicrotophos increases expression ISO RGD:1343110 6480464 dicrotophos results in increased expression of FNDC3B mRNA CTD PMID:28302478 diethyl maleate decreases expression ISO RGD:1551864 6480464 diethyl maleate results in decreased expression of FNDC3B mRNA CTD PMID:25270620 doxorubicin decreases expression ISO RGD:1343110 6480464 Doxorubicin results in decreased expression of FNDC3B mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1343110 6480464 entinostat results in increased expression of FNDC3B mRNA CTD PMID:27188386 folic acid multiple interactions ISO RGD:1551864 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:1551864 6480464 Folic Acid results in decreased expression of FNDC3B mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1343110 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of FNDC3B gene CTD PMID:31601247 furan increases expression ISO RGD:1551864 6480464 furan results in increased expression of FNDC3B mRNA CTD PMID:24183702 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of FNDC3B mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of FNDC3B mRNA CTD PMID:24136188 indometacin multiple interactions ISO RGD:1343110 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FNDC3B mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1343110 6480464 Ivermectin results in decreased expression of FNDC3B protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1551864 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of FNDC3B, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FNDC3B gene CTD PMID:20938992 leflunomide increases expression ISO RGD:1343110 6480464 leflunomide results in increased expression of FNDC3B mRNA CTD PMID:28988120 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of FNDC3B mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:1343110 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FNDC3B mRNA CTD PMID:26667767 methapyrilene increases methylation ISO RGD:1343110 6480464 Methapyrilene results in increased methylation of FNDC3B intron CTD PMID:30157460 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of FNDC3B mRNA CTD PMID:30467583 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of FNDC3B gene CTD PMID:35440735 methylmercury chloride increases expression ISO RGD:1343110 6480464 methylmercuric chloride results in increased expression of FNDC3B mRNA CTD PMID:28001369 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of FNDC3B gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FNDC3B mRNA CTD PMID:17602206 N-nitrosodiethylamine increases expression ISO RGD:1551864 6480464 Diethylnitrosamine results in increased expression of FNDC3B mRNA CTD PMID:24535843 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of FNDC3B mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1343110 6480464 Nickel results in increased expression of FNDC3B mRNA CTD PMID:24768652 , PMID:25583101 ochratoxin A decreases expression ISO RGD:1343110 6480464 ochratoxin A results in decreased expression of FNDC3B mRNA CTD PMID:30559759 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FNDC3B mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of FNDC3B mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1551864 6480464 Acetaminophen affects the expression of FNDC3B mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1551864 6480464 Acetaminophen results in increased expression of FNDC3B mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:1551864 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of FNDC3B mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:1343110 6480464 Acetaminophen results in decreased expression of FNDC3B mRNA CTD PMID:21420995 pentane-2,3-dione decreases expression EXP 6480464 2, 3-pentanedione results in decreased expression of FNDC3B mRNA CTD PMID:25710175 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of FNDC3B gene CTD PMID:33148267 phenobarbital affects expression ISO RGD:1551864 6480464 Phenobarbital affects the expression of FNDC3B mRNA CTD PMID:23091169 potassium chromate multiple interactions ISO RGD:1343110 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FNDC3B mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1343110 6480464 potassium chromate(VI) results in decreased expression of FNDC3B mRNA CTD PMID:22079256 propanal increases expression ISO RGD:1343110 6480464 propionaldehyde results in increased expression of FNDC3B mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:1551864 6480464 propiconazole results in increased expression of FNDC3B mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1343110 6480464 Quercetin results in decreased expression of FNDC3B mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1343110 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FNDC3B mRNA CTD PMID:26667767 rimonabant multiple interactions ISO RGD:1551864 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of FNDC3B mRNA] CTD PMID:19030233 senecionine decreases expression ISO RGD:1551864 6480464 senecionine results in decreased expression of FNDC3B protein CTD PMID:35357534 silicon dioxide increases expression ISO RGD:1551864 6480464 Silicon Dioxide results in increased expression of FNDC3B mRNA CTD PMID:23221170 sodium fluoride decreases expression ISO RGD:1551864 6480464 Sodium Fluoride results in decreased expression of FNDC3B mRNA CTD PMID:27862939 sulforaphane multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of FNDC3B mRNA CTD PMID:25450479 testosterone decreases expression ISO RGD:1551864 6480464 Testosterone deficiency results in decreased expression of FNDC3B mRNA CTD PMID:33848595 tetrachloromethane increases expression ISO RGD:1551864 6480464 Carbon Tetrachloride results in increased expression of FNDC3B mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FNDC3B mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FNDC3B mRNA] CTD PMID:31150632 thapsigargin increases expression ISO RGD:1343110 6480464 Thapsigargin results in increased expression of FNDC3B mRNA CTD PMID:22378314 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FNDC3B mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FNDC3B mRNA CTD PMID:25729387 triptonide decreases expression ISO RGD:1551864 6480464 triptonide results in decreased expression of FNDC3B mRNA CTD PMID:33045310 tunicamycin increases expression ISO RGD:1343110 6480464 Tunicamycin results in increased expression of FNDC3B mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:1551864 6480464 Valproic Acid affects the expression of FNDC3B mRNA CTD PMID:17292431 , PMID:17963808 valproic acid increases expression ISO RGD:1343110 6480464 Valproic Acid results in increased expression of FNDC3B mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:1343110 6480464 Valproic Acid affects the expression of FNDC3B mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of FNDC3B mRNA CTD PMID:19015723 vorinostat increases expression ISO RGD:1343110 6480464 vorinostat results in increased expression of FNDC3B mRNA CTD PMID:27188386